Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
3.200
-0.080 (-2.44%)
At close: Aug 21, 2026, 4:00 PM EDT
3.260
+0.060 (1.87%)
After-hours: Aug 21, 2026, 7:48 PM EDT
Decoy Therapeutics Market Cap
Decoy Therapeutics has a market cap or net worth of $2.1 million as of August 21, 2026. Its market cap has decreased by -24.39% in one year.
Market Cap
2.10M
Enterprise Value
-6.19M
1-Year Change
-24.39%
Ranking
Category
Stock Price
$3.20
ChartMarket Cap Chart
Since July 22, 2019, Decoy Therapeutics's market cap has decreased from $44.18M to $2.10M, a decrease of -95.25%. That is a compound annual growth rate of -34.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 2.10M | -49.38% |
| Dec 31, 2025 | 4.14M | 56.21% |
| Dec 31, 2024 | 2.65M | 3.58% |
| Dec 29, 2023 | 2.56M | -26.55% |
| Dec 30, 2022 | 3.49M | -84.43% |
| Dec 31, 2021 | 22.39M | 3.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 3.00M |
| Matinas BioPharma Holdings | 2.92M |
| Valion Bio | 2.72M |
| Clearmind Medicine | 2.58M |
| Onconetix | 2.57M |
| Virax Biolabs Group | 2.54M |
| Propanc Biopharma | 2.46M |
| Oragenics | 2.37M |